Terence Flanagan (Dublin North East, Renua Ireland)
Link to this: Individually | In context | Oireachtas source

131. To ask the Minister for Health his views on a matter regarding medication; and if he will make a statement on the matter. [33505/15]

Patrick O'Donovan (Limerick, Fine Gael)
Link to this: Individually | In context | Oireachtas source

133. To ask the Minister for Health his views on a medical matter (details supplied); and if he will make a statement on the matter. [33517/15]

Michael Healy-Rae (Kerry South, Independent)
Link to this: Individually | In context | Oireachtas source

140. To ask the Minister for Health if he will confirm that the drug Fampyra is going to be funded by the Health Service Executive from October 2015; and if he will make a statement on the matter. [33579/15]

Kathleen Lynch (Cork North Central, Labour)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 131, 133 and 140 together.

The HSE has confirmed that Fampridine (brand name Fampyra®) will be reimbursed on the Long Term Illness Scheme from 1 October 2015. Reimbursement will be extended where a demonstration of clinical response (based on objective criteria agreed with clinical experts) is recorded and where that clinical response is shown to persist, based on objective measurement at six-month intervals.